Earn rewards for your opinion on lab products.
Get exclusive insights into life science trends.
Stay up to date on research news.
October 19, 2020 -- A research team has strengthened COVID-19 drug repurposing workflows through independent in vitro validation followed by clinical pharmacology data assessments, with the goal of launching clinical studies of currently approved drugs. The protocol was published in ACS Pharmacology & Translational Science on October 14. Discuss
October 16, 2020 -- Developing well-characterized adeno-associated viral vectors (AAVs) is a significant obstacle for the biomanufacturing industry. A group of analytical researchers is trying to overcome this challenge by developing novel analytical methodology specifically designed for AAVs. Discuss
October 15, 2020 -- A new retrospective study reveals that asymptomatic COVID-19 patients may have higher levels of lymphocytes, specifically T cells, compared to symptomatic COVID-19 patients despite carrying similar viral loads. The results were published in mSphere on October 7. Discuss
October 14, 2020 -- A new approach to RNA sequencing can enable scientists to extract 10 times more information from a single cell, including gene expression and subtle differences between healthy and diseased cells. The study, published in Immunity on October 13, reveals the power of the improved Seq-Well method and provides evidence of its efficacy in five inflammatory skin diseases. Discuss
October 13, 2020 -- In order to determine optimal cell growth conditions for the development of cellular therapies, researchers have devised an algorithm called EpiMorgify that can predict what factors are needed to produce high-quality cultures. The study was published on October 9 in Cell Systems. Discuss
October 12, 2020 -- Can antibodies developed against SARS-CoV during the 2003 outbreak be used to prevent infection by SARS-CoV-2? In an October 9 study published in Science Advances, researchers analyzed precious serum collected from convalescent SARS-CoV patients to find out. Discuss
October 9, 2020 -- Researchers have discovered that immunoglobulin G (IgG) antibodies to the SARS-CoV-2 virus are longer lasting in the blood and saliva of COVID-19 patients compared to the relatively short-lived IgM and IgA responses. The finding, presented in a pair of studies published in Science Immunology on October 8, suggests that IgG antibodies could be a promising target to detect and evaluate immune responses to the virus. Discuss
October 8, 2020 -- What impact will mutation of the SARS-CoV-2 virus have on the effectiveness of COVID-19 vaccines that are in development? In a new study published in NPJ Vaccines on October 8, Australian researchers say they believe that a recent change in the genetic material of the virus shouldn't reduce the effectiveness of vaccines coming to market. Discuss
October 7, 2020 -- The U.S. Food and Drug Administration (FDA) on October 6 issued a new guidance with recommendations for developers of COVID-19 vaccines regarding the scientific data and information that would be required to support emergency use authorization (EUA) for the products. Discuss
October 6, 2020 -- Specialized nanoparticles can be used to deliver small interfering RNA to the bone marrow where they can turn off specific genes in bone-marrow endothelial cells to help treat heart disease or boost stem cell production, according to new research published in Nature Biomedical Research on October 5. Discuss
October 5, 2020 -- Despite broad interest in determining the origin of SARS-CoV-2 in the early days of the COVID-19 pandemic, the existence of an intermediate host between the source of the virus in bats and humans remains unknown. A study published in Scientific Reports on October 5 provides evidence that 26 species of mammals that are regularly in contact with humans may be susceptible to infection. Discuss
October 2, 2020 -- This year's deluge of COVID-19 research publications has allowed substandard research to be published by academic journals or to be housed on preprint servers, resulting in the retraction of some papers. The chaotic publishing environment has potentially harmful implications for COVID-19 patients during treatment, a leading bioethicist wrote in a brief published in the Journal of Medical Ethics on October 1. Discuss
Science In Brief
Webinars/Videos
Job Boards
Conferences
Cell and Gene Therapy Bioprocessing and Commercialization
October 19-22
Online
October 19-22
Online
New Applications of Synthetic Biology to Cancer Research Challenges: 2020 Virtual Jumpstart
October 26-30
Online
October 26-30
Online
Japan Analytical & Scientific Instruments Show (JASIS)
November 11-13
Chiba, Chiba Japan
November 11-13
Chiba, Chiba Japan
2020 AACC Annual Scientific Meeting & Clinical Lab Expo
December 13-17
Online
December 13-17
Online
Society for Laboratory Automation and Screening (SLAS) 2021
January 23-27, 2021
San Diego, California United States
January 23-27, 2021
San Diego, California United States
Connect
Latest Tweets